<table id="table7" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7. Mean Pharmacokinetic Parameters<footnote>The majority of parameter means determined in each study had coefficients of variation between 20% and 40% for half-life and CL/F and between 30% and 70% for T<sub>max</sub>. The overall mean values were calculated from individual study means that were weighted based on the number of volunteers/subjects in each study. The numbers in parentheses below each parameter mean represent the range of individual volunteer/subject values across studies.</footnote> of Immediate-Release Lamotrigine in Healthy Volunteers and Adult Subjects with Epilepsy</caption>
<col align="left" valign="middle" width="35%"></col>
<col align="center" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="21%"></col>
<col align="center" valign="middle" width="26%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule" valign="bottom">Adult Study Population</th>
<th stylecode="Rrule" valign="bottom">Number of Subjects</th>
<th stylecode="Rrule" valign="bottom">t<sub>½</sub>: Elimination Half-life (h)</th>
<th stylecode="Rrule" valign="bottom">CL/F: Apparent Plasma Clearance (mL/min/kg)</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<content stylecode="bold">Healthy volunteers taking no other medications:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Single-dose lamotrigine</td>
<td stylecode="Rrule">179</td>
<td stylecode="Rrule">32.8<br/>(14.0-103.0)</td>
<td stylecode="Rrule">0.44<br/>(0.12-1.10)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Multiple-dose lamotrigine</td>
<td stylecode="Rrule">36</td>
<td stylecode="Rrule">25.4<br/>(11.6-61.6)</td>
<td stylecode="Rrule">0.58<br/>(0.24-1.15)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<content stylecode="bold">Healthy volunteers taking valproate:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Single-dose lamotrigine</td>
<td stylecode="Rrule">6</td>
<td stylecode="Rrule">48.3<br/>(31.5-88.6)</td>
<td stylecode="Rrule">0.30<br/>(0.14-0.42)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Multiple-dose lamotrigine</td>
<td stylecode="Rrule">18</td>
<td stylecode="Rrule">70.3<br/>(41.9-113.5)</td>
<td stylecode="Rrule">0.18<br/>(0.12-0.33)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<content stylecode="bold">Subjects with epilepsy taking valproate only:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Single-dose lamotrigine</td>
<td stylecode="Rrule">4</td>
<td stylecode="Rrule">58.8<br/>(30.5-88.8)</td>
<td stylecode="Rrule">0.28<br/>(0.16-0.40)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<content stylecode="bold">Subjects with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone<footnote id="t7f1">Carbamazepine, phenytoin, phenobarbital, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives and other drugs, such as rifampin and protease inhibitors lopinavir/ritonavir and atazanavir/ritonavir, that induce lamotrigine glucuronidation have also been shown to increase the apparent clearance of lamotrigine <content stylecode="italics">[see <linkhtml href="#S7">Drug Interactions (7)</linkhtml>]</content>.</footnote> plus valproate:</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Single-dose lamotrigine</td>
<td stylecode="Rrule">25</td>
<td stylecode="Rrule">27.2<br/>(11.2-51.6)</td>
<td stylecode="Rrule">0.53<br/>(0.27-1.04)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<content stylecode="bold">Subjects with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone:</content>
<footnoteref idref="t7f1"></footnoteref>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">  Single-dose lamotrigine</td>
<td stylecode="Rrule">24</td>
<td stylecode="Rrule">14.4<br/>(6.4-30.4)</td>
<td stylecode="Rrule">1.10<br/>(0.51-2.22)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">  Multiple-dose lamotrigine</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">12.6<br/>(7.5-23.1)</td>
<td stylecode="Rrule">1.21<br/>(0.66-1.82)</td>
</tr>
</tbody>
</table>